Table: begin end state 1 11 cytoplasmic 12 30 transmembrane 31 50 non-cytoplasmic 51 74 transmembrane 75 82 cytoplasmic 83 102 transmembrane 103 105 non-cytoplasmic 106 106 transmembrane 107 107 non-cytoplasmic 108 130 transmembrane 131 142 cytoplasmic 143 164 transmembrane 165 176 non-cytoplasmic 177 198 transmembrane 199 256 cytoplasmic 257 279 transmembrane 280 294 non-cytoplasmic 295 315 transmembrane 316 326 cytoplasmic 327 345 transmembrane 346 350 non-cytoplasmic 351 375 transmembrane 376 385 cytoplasmic 386 404 transmembrane 405 414 non-cytoplasmic 415 435 transmembrane 436 469 cytoplasmic
Input: >NP_347967.1 NCBI__GCF_000008765.1:NP_347967.1 MGENNSHKHSLLFIVLISCAAGLGGLLYGYDTAVISGAIGFLKKLYNLSPAMQGFVISSI MVGGVLGVGFSGFLGDAIGRRKVLMLAAALFAISAVISSISTSAFMLIFARIVGGLGIGM ASALSVTYITECAPPSIRGRLSSLYQLFTILGISITFFVNLGIVNMGSETWRVSTGWRYM LACGTVPAIVFLITLFFVPESPRFLVKSGNIKKAAAVLTKINGAEIAKQELDSISKSLAT ENDSSLGQLLQPGLRRALLIGIFLAIFNQAIGMNSITYYGPEIFQMIGFKNNSSFLATSV IGVVEVFSTILAMFLIDKLGRKKLMEIGSAAMAVFMLLIGTSFYIKLSNGFVILIFIICF VVSFCISMGPIPWIMIPEIFPNHLRARATGIATIFLWGANWAIGQFTPMLLNGIGGAYTF WIFCGINVICFLVVTTKVPETKNKSLEEIEKFWIPKSKQNAKGSSVGAK
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server